The U.S. Food and Drug Administration granted emergency use authorization for nitenpyram, a medication to treat New World screwworm infestations in dogs and cats. It is the first generic animal drug ...

Graceful degradation: If IfcOpenShell is not installed or the file is not found, the parser automatically returns a synthetic mock building (5 offices, a corridor, 3 doors, 1 exit, 1 stair) so the ...

The Trump administration on Monday said it is adding generic medications to its direct-to-consumer drug sales website, TrumpRx. The platform, which launched in February, is key to his administration's ...

The International Finance Corporation mobilizes private capital at scale, supports businesses from microenterprises to large corporations, and creates jobs that drive economic growth and reduce ...

Here’s how to invest in custom visuals and turn that content into years of stronger engagement, trust and brand differentiation. Custom visual content builds trust faster by showing real people, ...

A generic version of Wegovy is not currently available in the United States due to patents held by the manufacturer, Novo Nordisk, that may remain in effect until 2041. When the U.S. patent for ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

Apps that record visits are becoming popular, but they come with privacy and accuracy concerns. By Simar Bajaj At your next appointment, your doctor may have a new kind of assistant listening in: ...

Abstract: This study presents a Python-based framework for converting IFC data into RDF triples, ensuring semantic integrity and interoperability in BIM environments. Using the SemanIFC library for ...

The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this weekend to start selling generic versions of Ozempic and Wegovy, with several ...